If you use oral contraceptives, consider using a non-oral method or adding a barrier method for 4 weeks after starting tirzepatide and after each dose escalation
#Pharmaceuticals #Biotech #MICROTAG #PrecisionTherapeutics #DrugDiscovery #CellTargetEngagement #DrugTargeting #ChallengingTarget #DrugTarget #BiotechInnovation #TherapeuticDiscovery #BiomedicalInnovation #CellarisBio #DEL #Biotech #Pharma #BiotechAdvancements #PrecisionMedicine #BiotechInnovation To view or add a comment, sign in I have to say I am impressed with the FDAs decision to start looking at the totality of evidence rather than redundant clinical endpoints
(Do not use this tier just to treat GLP-1 sulfur burps)
Cernea S
This systematic review, conducted by researchers from the Beijing University of Chinese Medicine and the University of Chicago, analyzed data from 76 studies to assess the safety and efficacy of fifteen glucagon-like peptide-1 (GLP-1) receptor agonists used in the treatment of type 2 diabetes
So great and nothing harmful to my So great and nothing harmful to my health, i will keep going with nurx I like the transparency of this I like the transparency of this company's approach, they make it easy to get the help you need for the concerns that you experience